Skip to main content
Douglas Krakower, MD, Infectious Disease, Boston, MA, Beth Israel Deaconess Medical Center

DouglasScottKrakowerMD

Infectious Disease Boston, MA

HIV/AIDS Medicine, STD Medicine, Clinical Informatics

Faculty, Beth Israel Deaconess Medical Center, Harvard Medical School

Dr. Krakower is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

  • Connect with other colleagues in the same hospital or clinic
  • Search all U.S. specialist profiles and refer a patient
  • Read the latest clinical news and earn CME/CEU credits

See Dr. Krakower's full profile

Already have an account?

Education & Training

  • Beth Israel Deaconess Medical Center
    Beth Israel Deaconess Medical CenterFellowship, Infectious Disease, 2009 - 2012
  • Massachusetts General Hospital/Harvard Medical School
    Massachusetts General Hospital/Harvard Medical SchoolResidency, Internal Medicine/Pediatrics, 2004 - 2008
  • Harvard Medical School
    Harvard Medical SchoolClass of 2004

Certifications & Licensure

  • MA State Medical License
    MA State Medical License 2007 - 2026
  • American Board of Internal Medicine Infectious Disease

Clinical Trials

Publications & Presentations

PubMed

Journal Articles

  • Public Health Detailing for HIV Pre-Exposure Prophylaxis  
    Alex S Keuroghlian, Douglas S Krakower, Demetre Daskalakis, Clinical Infectious Diseases

Lectures

  • Will the Newest Pill for HIV Prevention Fuel Progress — or Profits? 
    Beth Israel Deaconess Hospital - Needham , Harvard Medical School ,Department Of Continuing Educatio - 5/30/2013

Press Mentions

  • A Little Blue Pill That Protects You from HIV — if You Use It
    A Little Blue Pill That Protects You from HIV — if You Use ItJanuary 29th, 2021
  • Antibiotics as STD Prophylaxis in Addition to PrEP?
    Antibiotics as STD Prophylaxis in Addition to PrEP?October 29th, 2020
  • Trans and Cis Women and Men All Have Similar Levels of PrEP Drugs in Blood, Directly-Observed Dosing Study Finds
    Trans and Cis Women and Men All Have Similar Levels of PrEP Drugs in Blood, Directly-Observed Dosing Study FindsSeptember 7th, 2020
  • Join now to see all

Hospital Affiliations